-
Most Recent
HEXO
Hexo Stock Can Bounce Back From Deeply Oversold Levels
Hexo stock is oversold and presents a buying opportunity. The company is building a strong foundation for growth and margin expansion.
Take Another Look at HEXO Stock After Last Week’s Sell-Off
Until the general selloff in cannabis stocks eases, investors should first wait for the stock to settle. The company does not report quarterly results until around September. Strong revenue could help investors re-establish confidence in the company.
Hexo Stock Has Potential, But Skip It for Now
The Canadian market has runway with edibles and beverages. But the real growth driver is the United States. Once Hexo and its competitors can expand south into America, investors will have a clearer picture of the industry's growth potential. Until then, the stock is not a buy. But long-term, HEXO stock may be a smart way to play the cannabis growth story.
Cannabis Bulls Should Consider HEXO Stock … Eventually
HEXO stock is a classic falling knife right now, but could be a value play once it finds a bottom.
Why HEXO Stock Is Interesting, But Not Compelling
HEXO stock is interesting, but it's not a compelling investment because HEXO probably won;t become a major player in the cannabis space.
Owning Hexo Stock Requires a Longer-Term Mindset
HEXO stock is losing ground like most other pot stocks, but management is most definitely building a differentiated company.
Why I Still Believe in Canopy Growth Stock and the Weed Market
While CGC stock has serious challenges impacting it, the headwinds do not directly impugn Canopy's core business potential.
3 Reasons Investors Should Be High on Hexo Stock
It’s been a roller coaster year for Hexo stock. But for the most part, the valuation looks reasonable right now. There are also a few catalysts that should help reinvigorate the stock price.
3 Reasons Why HEXO Stock Is the Real Deal
With its cannabis-beverage partnerships and major acquisitions, HEXO stock is a legitimate contender in the cannabis space.
The Firing of Canopy Growth’s co-CEO Is Only Part of the Case Against CGC Stock
CGC stock is suddenly a liability after the industry's problems started to weigh on CGC stock price in recent weeks
The NYSE Listing Means Legitimacy and Bigger Things for Hexo Stock
Soon, Hexo Corp stock will trade on the New York Stock Exchange, giving the company and the industry a desperately needed credibility boost.
Cronos Needs to Show the Market Something to Pull Stock Out of Funk
CRON stock is putting pressure on the 200-day moving average line, as a floor, and Cronos Group can to little to relieve it.
Why Hexo Stock Is a Promising Buy Now
The company’s tie to the U.S. is a much bigger deal for HEXO stock than first thought. Here's everything you need to know about Hexo now.
Tilray Prepares a Second Act That Could Rekindle TLRY Stock
Tilray stock has conspicuously taken a beating relative to the major cannabis players, but the underlying company's presence in the U.K. could change the narrative.
Bears May Have Gotten Too Pessimistic Too Fast on Hexo Stock
Hexo stock price can rise meaningfully if HEXO's revenue growth meets expectations over the next 12 months.
Hexo Stock Remains Attractive Despite Revenue Miss
Although HEXO's top line missed, traders need to look at the market position of HEXO before deciding to sell Hexo stock.
Hexo Stock Has An Earnings Buzz Kill That Simply Isn’t Deserved
HEXO stock took a hit on disappointing earnings. This could be temporary as Hexo ramps up for CBD opportunities.
Hexo Stock May Be the Cannabis Industry’s Best-Kept Secret
HEXO stock is sure to remain volatile, but aside from the volatility, HEXO is quietly one of the most reasonable, sound picks in the business.
Underappreciated CBD Market Is The Key For HEXO Stock
As a speculative cannabis play, HEXO stock has recently experienced volatility but patience toward its CBD potential could yield longer-term upside.
